OAM
EW icon

OP Asset Management’s Edwards Lifesciences EW Stock Holding History

OP Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.78M Sell
63,844
-211,098
-77% -$17.7M 0.06% 233
2026
Q1 		$22M Buy
274,942
+137,934
+101% +$11.4M 0.19% 73
2025
Q4 		$11.7M Buy
137,008
+73,240
+115% +$6.01M 0.14% 117
2025
Q3 		$4.96M Buy
63,768
+2,212
+4% +$173K 0.07% 226
2025
Q2 		$4.81M Sell
61,556
-883
-1% -$65.9K 0.07% 218
2025
Q1 		$4.53M Buy
+62,439
New +$4.47M 0.08% 223

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

OP Asset Management's EW Position: Q2 2026 in Review

OP Asset Management reduced its Edwards Lifesciences (EW) stake by 77% in Q2 2026, selling an estimated $17.7M and leaving 63,844 shares worth $5.78M. The position accounts for 0.06% of the portfolio, ranked #233.

OP Asset Management first reported a position in EW in Q1 2025 and has held it in 6 quarters since. The position peaked at $22M in Q1 2026. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • OP Asset Management held 63,844 shares of Edwards Lifesciences worth $5.78M as of Q2 2026.
  • OP Asset Management sold 211,098 Edwards Lifesciences shares in Q2 2026, an estimated $17.7M.
  • Edwards Lifesciences made up 0.06% of OP Asset Management's portfolio in Q2 2026, its #233 holding.
  • OP Asset Management first reported a position in Edwards Lifesciences in Q1 2025 and has held it in 6 quarters since.
  • OP Asset Management's Edwards Lifesciences position peaked at $22M in Q1 2026.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.